Going anti-Viral

Going Anti-Viral

HIV

Covid-19

Vaccination

Long COVID

Glp-1 Receptor Agonists

Substance Use Disorder

Influenza

Opioids

Emerging Infections

Measles

Avian Influenza

H5N1

Fentanyl

Diabetes

Obesity

Public Health

Pediatric Infectious Diseases

Buprenorphine

Naloxone

Prep

Introducing Going anti-Viral, the podcast of the IAS–USA, a professional continuing medical education organization focused on HIV and other viral diseases. I’m Dr Michael Saag, professor emeritus of medicine and infectious diseases at the University of Alabama at Birmingham and volunteer member of the IAS–USA Board of Directors. Join us as we interview experts in viral medicine about their area o... more

22 ratings

Publishes	Twice monthly	Episodes	76	Founded	2 years ago
Number of Listeners		Categories	Health & FitnessMedicine

Listen to this Podcast

Guests Hosts Reviews Charts Talking Points

Latest Episodes

Cognitive Aging in HIV: Clinical Assessment and Management – Dr Shibani Mukerji

In episode 75 of Going anti-Viral, Dr Shibani Mukerji joins host Dr Michael Saag to discuss a presentation she gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Cognitive Aging in HIV: Clinical Assessment and Ma... more

Yesterday • 37 min

Immunology of HIV Cure and Beyond: Navigating Immunology Presentations at CROI 2026 – Dr John Frater

In episode 74 of Going anti-Viral, Dr John Frater joins host Dr Michael Saag to discuss a presentation he gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Immunology of HIV Cure and Beyond: Navigating Immunolog... more

7 Apr 2026 • 27 min

YouTube

Special Episode - Latest Update on Emerging Infections and Health Threats

In episode 73 of Going anti-Viral, we represent a panel discussion from March 26, 2026, as part of the IAS–USA Dialogue series Emerging Infections and Health Threats. This Dialogue is a must listen as our distinguished panel of infectious disease exp... more

1 Apr 2026 • 1 hr 4 min

YouTube

Neurodegeneration and Dementia Risk in Older Adults with HIV: Biomarkers and Epidemiology – Dr Alan Winston

In episode 72 of Going anti-Viral, Dr Alan Winston joins host Dr Michael Saag to discuss a presentation he gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Neurodegeneration and Dementia Risk in Older Adults Wi... more

24 Mar 2026 • 28 min

YouTube

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

FebrileSara Dong

ThroughlineNPR

This Week in VirologyVincent Racaniello

The InterviewThe New York Times

The NPR Politics PodcastNPR

Recent Guests

John Frater

Professor of Infectious Diseases leading the HIV Reservoir and Cure Group at University of Oxford

University of Oxford

Episode: Immunology of HIV Cure and Beyond: Navigating Immunology Presentations at CROI 2026 – Dr John Frater

Bonnie Maldonado

Professor of Pediatrics and Global Health, Stanford University

Stanford University

Episode: Special Episode - Latest Update on Emerging Infections and Health Threats

Peter Chin-Hong

Professor, Division of Infectious Diseases, UCSF

University of California, San Francisco

Episode: Special Episode - Latest Update on Emerging Infections and Health Threats

Alan Winston

Professor of HIV and genitourinary medicine at Imperial College London; consultant physician at St. Mary's Hospital London

Imperial College London; St. Mary's Hospital London

Episode: Neurodegeneration and Dementia Risk in Older Adults with HIV: Biomarkers and Epidemiology – Dr Alan Winston

Dr. Peter Hunt

Professor of Medicine at the University of California, San Francisco; Associate Chief for Research, UCSF Department of Medicine; Co-Director, UCSF Bay Area Center for AIDS Research for Basic and Translational Science

University of California, San Francisco

Episode: CROI 2026 Review: What’s New, What’s Next in HIV Research – Dr Peter Hunt

Peter Staley

Leading HIV and LGBTQ rights activist; founder of TAG and involved with ACT UP NYC

Treatment Action Group (TAG); ACT UP NYC

Episode: From Wall Street to ACT UP: A Life Rewritten by HIV - Peter Staley

Kevin Saunders

Associate Director, Duke Human Vaccine Institute; Norman Letvin Professor in Immunology and Infectious Disease Research, Duke University

Duke University

Episode: Successes in HIV-1 Vaccine Design: Accelerating Completion of One of Sciences’ Most Difficult Vaccines – Dr Kevin Saunders

Dr Ruanne Barnabas

Chief of Infectious Diseases at Massachusetts General Hospital, Boston; moderator of the symposium

Massachusetts General Hospital

Episode: Strategic and Resilient Responses to the Funding Crisis Across Africa – Dr Ruanne Barnabas

Martin Hirsch

Professor Emeritus at Harvard Medical School

Harvard Medical School

Episode: Reflections on a Career of HIV Medicine, Mentorship, and Scientific Legacy – Dr Martin Hirsch

Hosts

Dr. Michael Saag

Professor of Medicine and Infectious Diseases; longtime leader in HIV research and public health advocacy; serves as host and clinical educator.

Michael Saag

Host with a background in clinical HIV research and advocacy; closely tied to IAS-USA.

Reviews

4.8 out of 5 stars from 22 ratings

So inspiring to hear Dr Friedland ‘s lifetime journey in care and research in HIV.
Audible
5
Donna Jacobsen
United States3 months ago
Outstanding Content for practitioner and lay person alike!
This podcast series has a wealth of actionable items for clinical decision makers as well as being highly informative (and entertaining!) to anyone interested in current public health challenges and opportunities. Can’t wait for the next pod drop - BRAVO !
Apple Podcasts
5
Moosesgod#10
United States5 months ago
Amazing podcast!
I love hearing Dr saag lecture at various meetings and curbsiders podcast. So excited to hear him have his own podcast. So educational.
Apple Podcasts
5
GoldenKinako
United States5 months ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners praise practical, clinician-focused insights and actionable takeaways.

The host is described as educational and engaging, blending lectures with accessible discussion.

Guests are highlighted for their depth and relevance to HIV research and policy.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts	#80	United Arab Emirates/Health & Fitness/Medicine
Apple Podcasts	#127	Colombia/Health & Fitness/Medicine

Talking Points

Recent interactions between the hosts and their guests.

Immunology of HIV Cure and Beyond: Navigating Immunology Presentations at CROI 2026 – Dr John Frater

Q: What strategies are most promising for targeting the reservoir — wake it up or other approaches?

A combination approach seems most plausible: using neutralizing antibodies to target virus and enhance immune clearance, alongside T-cell–based strategies to identify and destroy latently infected cells, with consideration of wake-up strategies (kick) to expose latent cells while maintaining control of infection, and exploring potential gene-editing avenues in the future.

Immunology of HIV Cure and Beyond: Navigating Immunology Presentations at CROI 2026 – Dr John Frater

Q: So then, how do you measure the latent reservoir?

Measurement is complex and evolving: initial measures of HIV DNA were largely defective or non-replicative; the field now emphasizes intact proviral DNA and outgrowth assays, recognizing that even some intact genomes may not be expressed upon stimulation, and that reservoir estimates must consider multiple tissues beyond blood to approximate a true total-body reservoir.

From Wall Street to ACT UP: A Life Rewritten by HIV - Peter Staley

Q: What led to the parallel track and the shift toward earlier access to treatment?

Activists pressured the FDA to speed up approvals and create a parallel track, alongside traditional trials, to get potentially life-saving drugs to patients who could not wait for full trial results.

Reflections on a Career of HIV Medicine, Mentorship, and Scientific Legacy – Dr Martin Hirsch

Q: What was the most pivotal moment in HIV research during your career?

The formation of AIDS Clinical Trials Groups and the rapid demonstration that combination therapies could dramatically improve outcomes was transformative, turning HIV into a chronic but controllable disease and enabling a generation of researchers to build on a solid, trial-driven foundation.

Reflections on a Career of HIV Medicine, Mentorship, and Scientific Legacy – Dr Martin Hirsch

Q: How did you balance mentorship with advancing cutting-edge research in a fast-moving field?

I focused on understanding each fellow as an individual, providing the right mix of independence and support, and giving them opportunities aligned with their strengths. Some needed more guidance, others thrived with autonomy; the key was to foster their growth while ensuring scientific integrity and appropriate credit.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Going anti-Viral

What is Going anti-Viral about and what kind of topics does it cover?

Across episodes, the show centers HIV, viral infections, and public health, with deep dives into conference highlights, vaccine development, funding landscapes, and policy implications. Guests range from leading researchers and clinicians to activists and public health leaders, producing a mix of cutting-edge science, historical context, and practical insights for clinicians and program managers. Noteworthy are in-depth looks at CROI findings, vaccine design strategies, and activist movements that accelerated drug development and access, offering a blend of rigorous science and real-world impact that helps listeners understand how advances translate to patient care and health systems.

Where can I find podcast stats for Going anti-Viral?

Rephonic provides a wide range of podcast stats for Going anti-Viral. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Going anti-Viral and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Going anti-Viral get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Going anti-Viral, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Going anti-Viral?

Rephonic provides comprehensive predictive audience data for Going anti-Viral, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Going anti-Viral have?

To see how many followers or subscribers Going anti-Viral has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Going anti-Viral?

These podcasts share a similar audience with Going anti-Viral:

1. Febrile
2. Throughline
3. This Week in Virology
4. The Interview
5. The NPR Politics Podcast

How many episodes of Going anti-Viral are there?

Going anti-Viral launched 2 years ago and published 76 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Going anti-Viral?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Going anti-Viral?

Rephonic pulls ratings and reviews for Going anti-Viral from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Going anti-Viral?

Rephonic provides full transcripts for episodes of Going anti-Viral. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Going anti-Viral?

Recent guests on Going anti-Viral include:

1. John Frater
2. Bonnie Maldonado
3. Peter Chin-Hong
4. Alan Winston
5. Dr. Peter Hunt
6. Peter Staley
7. Kevin Saunders
8. Dr Ruanne Barnabas

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days